The
In a complaint filed in Washington federal court, the FTC said the deal would hinder innovation for medical devices used to treat a serious heart condition known as aortic regurgitation, where blood pumped from the heart leaks back into the chamber
JenaValve’s medical device was approved in the European Union and is expected to receive approval from the Food and Drug Administration later this year.
Edwards best known for its valve used to treat another condition, aortic stenosis, ...